CD8A and ovarian cancer: Starting from a pool of 75 candidate predicted neo-epitopes from 20 ovarian cancer patients, Liu et al. identified 5 neo-epitope-specific CD8+ T cells in peripheral blood or TILs following expansion by mutant peptide pulsed autologous T cell-depleted PBMC APCs [25].